# FDA Updates Infant Formula Compliance Program

On October 6, 2023, the FDA published an updated infant formula compliance program describing its inspection, sampling, laboratory analysis, import oversight, and compliance procedures. The program outlines annual environmental sampling expectations for Cronobacter and Salmonella, notification procedures for positive findings or nutrient-level issues, and escalation rules for concerns identified through records reviews. It announces no contract or solicitation, but provides relevant compliance context for manufacturers and contractors supporting infant formula facilities.

- Manufacturers and service providers should review the program’s sampling, notification, and records-review procedures when planning facility support and quality-assurance work.
- Contractors supporting testing, laboratory analysis, import oversight, or compliance operations can use the program to understand the FDA activities and facility processes involved.
- The update is a compliance-program development, not a procurement announcement; the signal provides no solicitation details, contract value, or submission deadline.

**Jurisdictions:** federal
**Industries:** Healthcare
**Topics:** Regulatory Compliance
**Published:** November 20, 2026

### Government Entities
- U.S. Food and Drug Administration (FDA)
- Human Foods Program

### Sources
- [FDA Issues Updated Compliance Program for Infant Formula | FDA](https://www.fda.gov/food/fda-updates-food/fda-issues-updated-compliance-program-infant-formula) - F